Adaptive Biotechnologies Corp (ADPT) — Financial Flexibility Index

Latest as of September 2025: -0.02x

Adaptive Biotechnologies Corp (ADPT) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of $-6.72 Million (operating CF $-7.13 Million minus capex $409.00K) represents 0% of total liabilities ($286.36 Million). Also explore ADPT net assets growth trend to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.02x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-6.72 Million
Operating CF − Capex

Total Liabilities

$286.36 Million
USD

Capital Expenditures

$409.00K
USD

Adaptive Biotechnologies Corp Financial Flexibility Index (2017–2024)

Historical Financial Flexibility Index trend for Adaptive Biotechnologies Corp across 8 annual periods. Check Adaptive Biotechnologies Corp (ADPT) strategic asset index to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Adaptive Biotechnologies Corp (2017–2024)

Year-by-year free cash flow to debt coverage for Adaptive Biotechnologies Corp. For the full company profile including market capitalisation, see market cap of Adaptive Biotechnologies Corp.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -0.27x $-91.55 Million $-95.21 Million $336.89 Million ▲ +34.2%
2023 -0.41x $-145.63 Million $-156.32 Million $352.86 Million ▲ +3.3%
2022 -0.43x $-167.60 Million $-183.94 Million $392.52 Million ▼ -4.1%
2021 -0.41x $-130.98 Million $-192.73 Million $319.24 Million ▼ -17.0%
2020 -0.35x $-130.88 Million $-149.68 Million $373.15 Million ▼ -155.3%
2019 0.63x $216.60 Million $205.40 Million $341.26 Million ▲ +1545.5%
2018 -0.04x $-25.94 Million $-32.26 Million $590.80 Million ▲ +20.3%
2017 -0.06x $-32.35 Million $-34.86 Million $587.11 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities